Paullee
8 minutes ago
U.S. District Judge Amit P. Mehta, in a lengthy opinion, denied Jazz's motion for summary judgment and granted cross-motions brought by the FDA and intervenor Avadel CNS Pharmaceuticals LLC, agreeing with the agency that Jazz's narcolepsy drug Xywav and Avadel's Lumryz are not the "same drug," meani